Ten-year experience of smoking cessation in a single center in Japan

Tomioka, Haruaki; Wada, Takamasa; Yamazoe, Masatoshi; Yoshizumi, Yuko; Nishio, Chihiro; Ishimoto, Gakuji

doi:10.1016/j.resinv.2019.01.007

Cited by 8 publications

(13 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be because smokers with present diseases, especially smoking-related diseases such as cardiovascular diseases, COPD, are more concerned about their health and more eager to quit smoking. However, previous studies 14,18,23,29 demonstrated that having mental diseases was negatively associated with success of smoking cessation. This difference implies that smokers with different present diseases may have different smoking cessation behavior.…”

Section: Discussionmentioning

confidence: 90%

“…To the best of our knowledge, this is the first study to discuss the effects of providing financial support and factors associated with smoking cessation and relapse, based on financial support in Japan. From many studies 10-17 it is obvious that the completion of the SCT program improved the success of smoking cessation, while the completion rate was very low (68.0% 10 , 50.0% 11 , 36.3% 18 , 56.9% 19 , 32.4% 20 ). The completion rate of the SCT program in our study was 91.5%, which is far higher than in these previous studies and in three previous surveys 15-17 (30.0% in 2007, 35.5% in 2009, and 29.8% in 2017) reported by the Japanese Ministry of Health, Labor and Welfare.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment program: A prospective cohort study based on financial support in Suita City, Japan

Li¹,

Okamoto²,

Shirai³

2019

Tob. Induc. Dis.

View full text Add to dashboard Cite

INTRODUCTIONThe purpose of this study is to clarify the effect of providing financial support and factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment (SCT) program based on financial support.METHODSA prospective cohort study was conducted at the smoking cessation outpatients of hospitals or clinics in Suita City, Japan from May 2017 to September 2018. In all, 153 participants were recruited and received standardized treatment based on the SCT program. Participants were required to answer four questionnaires and register for the financial support program. Chi-squared test, Fisher’s exact test, non-paired t-test and log-binomial regression analysis were used to analyze the data.RESULTSOf the 153 participants, 140 participants completed a 12-week treatment and the completion rate was 91.5%. There were no factors significantly associated with smoking cessation and relapse (p<0.05). However, male, cigarettes smoked per day, having present diseases, having previous abstinence, living with family, cohabitation with smokers, desire to smoke at the start of treatment, self-efficacy at the start of treatment, desire to smoke at 4 weeks and self-efficacy at 4 weeks showed statistically significant odds ratio for success of smoking cessation. Similarly at 12 weeks, male, age at smoking initiation, cigarettes smoked per day, having previous abstinence, living with family, cohabitation with smokers, desire to smoke, self-efficacy and depression disorders showed statistically significant odds ratio for smoking relapse. In addition, the rate of abstainers using varenicline was 68.60%, which was higher than abstainers using nicotine patch (55.60%) and the relapse rate of participants using nicotine patch was 100.00%, significantly higher than for relapsers using varenicline (45.80%).CONCLUSIONSFurther study is expected to clarify the effect of providing financial support and the factors associated with smoking cessation and relapse in the SCT program based on financial support.

show abstract

Section: Discussionmentioning

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment program: A prospective cohort study based on financial support in Suita City, Japan

Li¹,

Okamoto²,

Shirai³

2019

Tob. Induc. Dis.

View full text Add to dashboard Cite

show abstract

“…This finding differs from the results in previous studies 19 , 29 , 30 . In their study, Huang et al 5 found that smokers with lower FTCD scores, those with lower exhaled CO concentrations, and those who smoked <20 cigarettes per day on average, had higher success rates. These differences in conclusions may be because our follow-up time was limited, the self-reports may have underestimated cigarette consumption, and only the first measurements of CO levels were compared.…”

Section: Discussionmentioning

confidence: 91%

“…This inconsistency may be because of differences between countries and regions. Some studies have found that measuring exhaled CO levels were a useful biomarker for predicting successful smoking cessation [3][4][5] . However, in our study, exhaled CO levels at the first visit were not associated with success in quitting.…”

Section: Discussionmentioning

confidence: 99%

“…According to the 2017 World Health Organization report [1][2][3][4][5] , tobacco smoking remains a major worldwide public health threat, with >7 million deaths directly related to tobacco. Many studies have recognized smoking as a risk factor for chronic diseases, such as chronic respiratory diseases (asthma, chronic obstructive pulmonary disease), hypertension, cardiovascular disease, atherosclerosis, diabetes, cancer, and microbial infections (respiratory infections, bacterial meningitis) 6,7 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Nomogram to predict successful smoking cessation in a Chinese outpatient population

Zhu¹,

Lin²,

Cao³

et al. 2020

Tob. Induc. Dis.

View full text Add to dashboard Cite

burdens healthcare systems and increases social costs. Given the impact of cigarette smoking, the development of effective interventions to address tobacco addiction is a major public health need. There are 350 million smokers in China, which accounts for one-third of the world's smokers 8. Unfortunately, smoking cessation services and counseling are at an early stage of development in China. Moreover, healthcare workers in China do not exert much effort in helping smokers to quit tobacco use 9. Therefore, the effectiveness of existing smoking cessation ABSTRACT INTRODUCTION The study aimed to establish and internally validate a nomogram to predict successful smoking cessation in a Chinese outpatient population. METHODS A total of 278 participants were included, and data were collected from March 2016 to December 2018. Predictors for successful smoking cessation were evaluated by 3-month sustained abstinence rates. Least absolute shrinkage and selection operator (LASSO) regression was used to select variables for the model to predict successful smoking cessation, and multivariable logistic regression analysis was performed to establish a novel predictive model. The discriminatory ability, calibration, and clinical usefulness of the nomogram were determined by the concordance index (C-index), calibration plot, and decision curve analysis, respectively. Internal validation with bootstrapping was performed. RESULTS The nomogram included living with a smoker or experiencing workplace smoking, number of outpatient department visits, reason for quitting tobacco, and varenicline use. The nomogram demonstrated valuable predictive performance, with a C-index of 0.816 and good calibration. A high C-index of 0.804 was reached with interval validation. Decision curve analysis revealed that the nomogram for predicting successful smoking cessation was clinically significant when intervention was conducted at a successful cessation of smoking possibility threshold of 19%. CONCLUSIONS This novel nomogram for successful smoking cessation can be conveniently used to predict successful cessation of smoking in outpatients.

show abstract

Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence

Hashimoto

Tomioka

Wada

et al. 2020

Respiratory Investigation

View full text Add to dashboard Cite

Ten-year experience of smoking cessation in a single center in Japan

Cited by 8 publications

References 22 publications

Factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment program: A prospective cohort study based on financial support in Suita City, Japan

Factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment program: A prospective cohort study based on financial support in Suita City, Japan

Nomogram to predict successful smoking cessation in a Chinese outpatient population

Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence

Contact Info

Product

Resources

About